• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by GBS Inc. (Amendment)

    2/5/24 4:18:51 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials
    Get the next $GBS alert in real time by email
    SC 13G/A 1 sc13ga110022inbs_02052024.htm

     UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13G

    (Rule 13d-102)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2(b)

    (Amendment No. 1)1

     

    Intelligent Bio Solutions Inc.

     (Name of Issuer)

    Common Stock, $.01 par value

     (Title of Class of Securities)

    36151G402

     (CUSIP Number)

    December 31, 2023

     (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

       ☐  Rule 13d-1(b)

       ☒  Rule 13d-1(c)

       ☐  Rule 13d-1(d)

     

     

     

    1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 36151G402

     

      1   NAME OF REPORTING PERSON  
             
            Bigger Capital Fund, LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
            (b) ☐
               
      3   SEC USE ONLY    
               
                 
      4   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Delaware  
    NUMBER OF   5   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         0  
    OWNED BY   6   SHARED VOTING POWER  
    EACH          
    REPORTING         Warrants to purchase 75,758 shares
    (See Item 4)*
     
    PERSON WITH   7   SOLE DISPOSITIVE POWER  
             
              0  
        8   SHARED DISPOSITIVE POWER  
               
              Warrants to purchase 75,758 shares
    (See Item 4)*
     
      9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            Warrants to purchase 75,758 shares
    (See Item 4)*
     
      10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ☐
           
               
      11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
             
            Less than one percent  
      12   TYPE OF REPORTING PERSON  
             
            PN  

      

    2

    CUSIP No. 36151G402

      1   NAME OF REPORTING PERSON  
             
            Bigger Capital Fund GP, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
            (b) ☐
               
      3   SEC USE ONLY    
               
                 
      4   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Delaware  
    NUMBER OF   5   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         0  
    OWNED BY   6   SHARED VOTING POWER  
    EACH          
    REPORTING         Warrants to purchase 75,758 shares
    (See Item 4)*
     
    PERSON WITH   7   SOLE DISPOSITIVE POWER  
             
              0  
        8   SHARED DISPOSITIVE POWER  
               
              Warrants to purchase 75,758 shares
    (See Item 4)*
     
      9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            Warrants to purchase 75,758 shares
    (See Item 4)*
     
      10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ☐
           
               
      11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
             
            Less than one percent  
      12   TYPE OF REPORTING PERSON  
             
            OO  

      

    3

    CUSIP No. 36151G402

     

      1   NAME OF REPORTING PERSON  
             
            District 2 Capital Fund LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
            (b) ☐
               
      3   SEC USE ONLY    
               
                 
      4   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Delaware  
    NUMBER OF   5   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         0  
    OWNED BY   6   SHARED VOTING POWER  
    EACH          
    REPORTING         Warrants to purchase 75,758 shares
    (See Item 4)*
     
    PERSON WITH   7   SOLE DISPOSITIVE POWER  
             
              0  
        8   SHARED DISPOSITIVE POWER  
               
              Warrants to purchase 75,758 shares
    (See Item 4)*
     
      9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            Warrants to purchase 75,758 shares
    (See Item 4)*
     
      10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ☐
           
               
      11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
             
            Less than one percent  
      12   TYPE OF REPORTING PERSON  
             
            PN  

      

    4

    CUSIP No. 36151G402

     

      1   NAME OF REPORTING PERSON  
             
            District 2 Capital LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
            (b) ☐
               
      3   SEC USE ONLY    
               
                 
      4   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Delaware  
    NUMBER OF   5   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         0  
    OWNED BY   6   SHARED VOTING POWER  
    EACH          
    REPORTING         Warrants to purchase 75,758 shares
    (See Item 4)*
     
    PERSON WITH   7   SOLE DISPOSITIVE POWER  
             
              0  
        8   SHARED DISPOSITIVE POWER  
               
              Warrants to purchase 75,758 shares
    (See Item 4)*
     
      9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            Warrants to purchase 75,758 shares
    (See Item 4)*
     
      10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ☐
           
               
      11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
             
            Less than one percent  
      12   TYPE OF REPORTING PERSON  
             
            PN  

      

    5

    CUSIP No. 36151G402

     

      1   NAME OF REPORTING PERSON  
             
            District 2 GP LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
            (b) ☐
               
      3   SEC USE ONLY    
               
                 
      4   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Delaware  
    NUMBER OF   5   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         0  
    OWNED BY   6   SHARED VOTING POWER  
    EACH          
    REPORTING         Warrants to purchase 75,758 shares
    (See Item 4)*
     
    PERSON WITH   7   SOLE DISPOSITIVE POWER  
             
              0  
        8   SHARED DISPOSITIVE POWER  
               
              Warrants to purchase 75,758 shares
    (See Item 4)*
     
      9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            Warrants to purchase 75,758 shares
    (See Item 4)*
     
      10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ☐
           
               
      11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
             
            Less than one percent  
      12   TYPE OF REPORTING PERSON  
             
            OO  

      

    6

    CUSIP No. 36151G402

     

      1   NAME OF REPORTING PERSON  
             
            District 2 Holdings LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
            (b) ☐
               
      3   SEC USE ONLY    
               
                 
      4   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            Delaware  
    NUMBER OF   5   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         0  
    OWNED BY   6   SHARED VOTING POWER  
    EACH          
    REPORTING         Warrants to purchase 75,758 shares
    (See Item 4)*
     
    PERSON WITH   7   SOLE DISPOSITIVE POWER  
             
              0  
        8   SHARED DISPOSITIVE POWER  
               
              Warrants to purchase 75,758 shares
    (See Item 4)*
     
      9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            Warrants to purchase 75,758 shares
    (See Item 4)*
     
      10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ☐
           
               
      11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
             
            Less than one percent  
      12   TYPE OF REPORTING PERSON  
             
            OO  

      

    7

    CUSIP No. 36151G402

     

      1   NAME OF REPORTING PERSON  
             
            Michael Bigger  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
            (b) ☐
               
      3   SEC USE ONLY    
               
                 
      4   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            USA  
    NUMBER OF   5   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         0  
    OWNED BY   6   SHARED VOTING POWER  
    EACH          
    REPORTING         Warrants to purchase 151,516*
    (See Item 4)*
     
    PERSON WITH   7   SOLE DISPOSITIVE POWER  
             
              0  
        8   SHARED DISPOSITIVE POWER  
               
              Warrants to purchase 151,516 shares*
    (See Item 4)*
     
      9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            Warrants to purchase 151,516 shares*
    (See Item 4)*
     
      10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ☐
           
               
      11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
             
            1.7%*  
      12   TYPE OF REPORTING PERSON  
             
            IN  

      

    8

    CUSIP No. 36151G402

    Item 1(a).Name of Issuer:

    Intelligent Bio Solutions Inc., a Delaware corporation.

    Item 1(b).Address of Issuer’s Principal Executive Offices:

    142 West 57th Street
    11th Floor
    New York, NY 10019

    Item 2(a).Name of Person Filing
    Item 2(b).Address of Principal Business Office or, if None, Residence
    Item 2(c).Citizenship

    Bigger Capital Fund, LP (“Bigger Capital”)
    2250 Red Springs Drive
    Las Vegas, NV 89135
    Citizenship: Delaware

    Bigger Capital Fund GP, LLC (“Bigger GP”)
    2250 Red Springs Drive
    Las Vegas, NV 89135
    Citizenship: Delaware

    District 2 Capital Fund LP (“District 2 CF”)
    175 W. Carver Street
    Huntington, NY 11743
    Citizenship: Delaware

    District 2 Capital LP (“District 2”)
    175 W. Carver Street
    Huntington, NY 11743
    Citizenship: Delaware

    District 2 GP LLC (“District 2 GP”)
    175 W. Carver Street
    Huntington, NY 11743
    Citizenship: Delaware

    District 2 Holdings LLC (“District 2 Holdings”)
    175 W. Carver Street
    Huntington, NY 11743
    Citizenship: Delaware

    Michael Bigger
    2250 Red Springs Drive
    Las Vegas, NV 89135
    Citizenship: USA

    Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.”

    9

    CUSIP No. 36151G402

    Item 2(d).Title of Class of Securities:

    Common Stock, $.01 par value.

    Item 2(e).CUSIP Number:

    36151G402

    Item 3.If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
        /x/ Not applicable.
           
      (a) / / Broker or dealer registered under Section 15 of the Exchange Act.
           
      (b) / / Bank as defined in Section 3(a)(6) of the Exchange Act.
           
      (c) / / Insurance company as defined in Section 3(a)(19) of the Exchange Act.
           
      (d) / / Investment company registered under Section 8 of the Investment Company Act.
           
      (e) / / An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
           
      (f) / / An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
           
      (g) / / A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
           
      (h) / / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
           
      (i) / / A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.
           
      (j) / / A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J).
           
      (k) / / Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
           
          If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

     

    Item 4.Ownership
    (a)Amount beneficially owned:

    As of December 31, 2023, Bigger Capital beneficially owned warrants to purchase 75,758 shares of Common Stock.

    10

    CUSIP No. 36151G402

    Bigger GP, as the general partner of Bigger Capital, may be deemed to beneficially own the 75,758 shares of beneficially owned by Bigger Capital.

    As of December 31, 2023, District 2 CF beneficially owned warrants to purchase 75,758 shares of Common Stock.

    District 2, as the investment manager of District 2 CF, may be deemed to beneficially own the 75,758 shares beneficially owned by District 2 CF.

    District 2 GP, as the general partner of District 2 CF, may be deemed to beneficially own the 75,758 shares beneficially owned by District 2 CF.

    District 2 Holdings, as the managing member of District 2 GP, may be deemed to beneficially own the 75,758 shares beneficially owned by District 2 CF.

    Mr. Bigger, as the managing member of Bigger GP and the managing member of District 2 Holdings, may be deemed to beneficially own the (i) 75,758 shares beneficially owned by Bigger Capital and (ii) 75,758 shares beneficially owned by District 2 CF.

    The foregoing should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of any shares owned by another Reporting Person. Each of Bigger GP and Mr. Bigger disclaims beneficial ownership of shares beneficially owned by Bigger Capital. Each of District 2, District 2 GP, District 2 Holdings and Mr. Bigger disclaims beneficial ownership of the shares beneficially owned by District 2 CF. The filing of this statement shall not be construed as an admission that any such person or entity is the beneficial owner of any such securities.

    (b)Percent of class:

    The following percentages are based on 8,734,381 shares of Common Stock outstanding as of November 3, 2023 based on information provided in the Company’s Form 10-Q for the period ended September 30, 2023 plus an additional amount to reflect the exercise of the warrants.

    As of the close of business on December 31, 2023, (i) each of Bigger Capital and Bigger GP may be deemed to beneficially own less than 1% of the outstanding shares, (ii) each of District 2 CF, District 2, District 2 GP and District 2 Holdings may be deemed to beneficially own less than 1% of the outstanding shares, and (iii) Mr. Bigger may be deemed to beneficially own approximately 1.7% of the outstanding shares.

    (c)Number of shares as to which such person has:
    (i)Sole power to vote or to direct the vote

    See Cover Pages Items 5-9.

    (ii)Shared power to vote or to direct the vote

    See Cover Pages Items 5-9.

    11

    CUSIP No. 36151G402

    (iii)Sole power to dispose or to direct the disposition of

    See Cover Pages Items 5-9.

    (iv)Shared power to dispose or to direct the disposition of

    See Cover Pages Items 5-9.

    Item 5.Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:[x].

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

    Not Applicable.

    Item 7.Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not Applicable.

    Item 8.Identification and Classification of Members of the Group.

    Exhibit 99.1 Previously Filed.

    Item 9.Notice of Dissolution of Group.

    Not Applicable.

    Item 10.Certifications.

    By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    12

    CUSIP No. 36151G402

    SIGNATURE

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: February 5, 2024

    BIGGER CAPITAL FUND, LP   BIGGER CAPITAL FUND GP, LLC
         
    By: Bigger Capital Fund GP, LLC, its general partner   By:

    /s/ Michael Bigger

            Michael Bigger
    By:

    /s/ Michael Bigger

        Managing Member
      Michael Bigger      
      Managing Member      
          DISTRICT 2 CAPITAL LP
             
    DISTRICT 2 CAPITAL FUND LP   By:

    /s/ Michael Bigger

            Michael Bigger
    By: District 2 GP LLC, its general partner     Managing Member
             
    By:

    /s/ Michael Bigger

         
      Michael Bigger   DISTRICT 2 HOLDINGS LLC
      Managing Member      
          By:

    /s/ Michael Bigger

            Michael Bigger
    DISTRICT 2 GP LLC     Managing Member
             
    By:

    /s/ Michael Bigger

         
      Michael Bigger  

    /s/ Michael Bigger

      Managing Member   MICHAEL BIGGER

     

    13

     

     

    Get the next $GBS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GBS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GBS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Towers Christopher bought 9,090 shares, increasing direct ownership by 1,151% to 9,880 units (SEC Form 4)

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/6/23 6:45:33 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    Sakiris Spiro Kevin bought 112,727 shares (SEC Form 4)

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/6/23 6:43:55 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sakiris Spiro Kevin (Amendment)

    4/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/10/23 6:09:05 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    Towers Christopher bought 9,090 shares, increasing direct ownership by 1,151% to 9,880 units (SEC Form 4)

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/6/23 6:45:33 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    Sakiris Spiro Kevin bought 112,727 shares (SEC Form 4)

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/6/23 6:43:55 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    SEC Filings

    View All

    SEC Form 8-K filed by GBS Inc.

    8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    2/9/24 5:05:16 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    SEC Form 10-Q filed by GBS Inc.

    10-Q - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    2/9/24 8:31:01 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

    8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    2/7/24 5:05:25 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology

    The transaction further solidifies GBS' leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reachGBS' global footprint includes operations in Australia, United Kingdom and the US NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) --  GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point of care, today announced it has acquired Intelligent Fingerprinting Limited (IFP), thus expanding the GBS platform of rapid, non-invasive diagnostic testing technologies. In addition, GBS announced it has begun the process of changing its corporate name. I

    10/4/22 9:05:00 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. Reports Fourth Quarter and Full Year ended June 30, 2022 Preliminary Financial Results and Recent Business Highlights

    - Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective acquisition - - Completed collection and analysis in a study with coincidental sampling of oral fluid and blood to evaluate the time-course of glucose in oral fluids - - Company to host conference call & webcast today at 4:30 p.m. ET - NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time monitoring and diagnostic testing for patients and their primary health practitioners at point of care, today announced its preliminary financial results for the fourth financi

    8/31/22 4:05:00 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31

    NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the fourth quarter and full year ended June 30, 2022, shortly after the NASDAQ market close on Wednesday, August 31. Management will then host a conference call and webcast at 4:30 p.m. ET. Title:GBS Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call & WebcastDate:Wednesday, August 31, 2022Time:4:30 p.m. ETConference Call Details:Toll-Free: 877-407-3982International: 201-493-6780Conference ID: 1

    8/29/22 9:05:00 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    Financials

    Live finance-specific insights

    View All

    GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology

    The transaction further solidifies GBS' leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reachGBS' global footprint includes operations in Australia, United Kingdom and the US NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) --  GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point of care, today announced it has acquired Intelligent Fingerprinting Limited (IFP), thus expanding the GBS platform of rapid, non-invasive diagnostic testing technologies. In addition, GBS announced it has begun the process of changing its corporate name. I

    10/4/22 9:05:00 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. Reports Fourth Quarter and Full Year ended June 30, 2022 Preliminary Financial Results and Recent Business Highlights

    - Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective acquisition - - Completed collection and analysis in a study with coincidental sampling of oral fluid and blood to evaluate the time-course of glucose in oral fluids - - Company to host conference call & webcast today at 4:30 p.m. ET - NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time monitoring and diagnostic testing for patients and their primary health practitioners at point of care, today announced its preliminary financial results for the fourth financi

    8/31/22 4:05:00 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31

    NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the fourth quarter and full year ended June 30, 2022, shortly after the NASDAQ market close on Wednesday, August 31. Management will then host a conference call and webcast at 4:30 p.m. ET. Title:GBS Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call & WebcastDate:Wednesday, August 31, 2022Time:4:30 p.m. ETConference Call Details:Toll-Free: 877-407-3982International: 201-493-6780Conference ID: 1

    8/29/22 9:05:00 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by GBS Inc. (Amendment)

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    2/14/24 6:04:24 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by GBS Inc. (Amendment)

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    2/13/24 8:08:30 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by GBS Inc. (Amendment)

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    2/5/24 4:18:51 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials